• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共刺激分子CD134与CD137通路耦合,诱导产生超效应性CD8 T细胞,这些细胞随后变得依赖白细胞介素-7。

CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.

作者信息

Lee Seung-Joo, Rossi Robert J, Lee Sun-Kyeong, Croft Michael, Kwon Byoung S, Mittler Robert S, Vella Anthony T

机构信息

Department of Immunology, University of Connecticut Health Center, Farmington, CT 06030, USA.

出版信息

J Immunol. 2007 Aug 15;179(4):2203-14. doi: 10.4049/jimmunol.179.4.2203.

DOI:10.4049/jimmunol.179.4.2203
PMID:17675480
Abstract

The TNFR superfamily members 4-1BB (CD137) and OX40 (CD134) are costimulatory molecules that potently boost CD8 and CD4 T cell responses. Concomitant therapeutic administration of agonist anti-CD137 and -CD134 mAbs mediates rejection of established tumors and fosters powerful CD8 T cell responses. To reveal the mechanism, the role of CD137 expression by specific CD8 T cells was determined to be essential for optimal clonal expansion and accumulation of effector cells. Nonetheless, dual costimulation induced production of supereffector CD8 T cells when either the specific T cells or the host alone bore CD137. Perhaps surprisingly, the total absence of CD137 prevented anti-CD134 augmentation of supereffector differentiation demonstrating an unappreciated link between these related pathways. Ultimately, it was reasoned that these powerful dual costimulatory responses involved common gamma family members, and we show substantial increases of CD25 and IL-7Ralpha-chain expression by the specific CD8 T cells. To investigate this further, it was shown that IL-7 mediated T cell accumulation, but importantly, a gradual and preferential effect of survival was directed toward supereffector CD8 T cells. In fact, a clear enhancement of effector differentiation was demonstrated to be proportional to the increasing amount of IL-7Ralpha expression by the specific CD8 T cells. Therefore, dual costimulation through CD137 and CD134 drives production and survival of supereffector CD8 T cells through a distinct IL-7-dependent pathway.

摘要

肿瘤坏死因子受体(TNFR)超家族成员4-1BB(CD137)和OX40(CD134)是共刺激分子,可有效增强CD8和CD4 T细胞反应。同时给予激动型抗CD137和抗CD134单克隆抗体进行治疗,可介导已形成肿瘤的排斥反应,并促进强大的CD8 T细胞反应。为揭示其机制,研究发现特定CD8 T细胞表达CD137对于效应细胞的最佳克隆扩增和积累至关重要。尽管如此,当特定T细胞或宿主单独表达CD137时,双重共刺激可诱导产生超效应CD8 T细胞。也许令人惊讶的是,完全缺乏CD137会阻止抗CD134增强超效应分化,这表明这些相关途径之间存在未被认识的联系。最终推断,这些强大的双重共刺激反应涉及常见的γ家族成员,并且我们发现特定CD8 T细胞的CD25和IL-7Rα链表达大幅增加。为进一步研究,结果表明IL-7介导T细胞积累,但重要的是,生存的逐渐和优先效应针对超效应CD8 T细胞。事实上,效应分化的明显增强与特定CD8 T细胞IL-7Rα表达量的增加成正比。因此,通过CD137和CD134的双重共刺激通过一条独特的IL-7依赖性途径驱动超效应CD8 T细胞的产生和存活。

相似文献

1
CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.共刺激分子CD134与CD137通路耦合,诱导产生超效应性CD8 T细胞,这些细胞随后变得依赖白细胞介素-7。
J Immunol. 2007 Aug 15;179(4):2203-14. doi: 10.4049/jimmunol.179.4.2203.
2
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.一种免疫治疗性 CD137 激动剂释放 CD4 T 细胞中 Eomesodermin 从 ThPOK 抑制中释放。
J Immunol. 2018 Feb 15;200(4):1513-1526. doi: 10.4049/jimmunol.1701039. Epub 2018 Jan 5.
3
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.自身抗原通过CD134和CD137双重共刺激来阻止CD8 T细胞效应分化。
J Immunol. 2008 Dec 1;181(11):7728-37. doi: 10.4049/jimmunol.181.11.7728.
4
A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors.4-1BB(CD137)和 OX40(CD134)受体共刺激 CD8 T 细胞的数学模型。
Sci Rep. 2019 Jul 26;9(1):10862. doi: 10.1038/s41598-019-47333-y.
5
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation.CD134 加 CD137 双重共刺激诱导 CD4 T 细胞中的 Eomesodermin 以编程细胞毒性 Th1 分化。
J Immunol. 2011 Oct 1;187(7):3555-64. doi: 10.4049/jimmunol.1101244. Epub 2011 Aug 31.
6
Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.肿瘤坏死因子受体超家族成员CD134(OX40)和CD137(4-1BB)的表达、共刺激作用及其在抗肿瘤免疫反应产生中的作用。
Eur J Immunol. 2002 Dec;32(12):3617-27. doi: 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M.
7
Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.CD137/4-1BB 通路共刺激可保护人黑色素瘤肿瘤浸润淋巴细胞免于激活诱导的细胞死亡,并增强抗肿瘤效应功能。
J Immunother. 2011 Apr;34(3):236-50. doi: 10.1097/CJI.0b013e318209e7ec.
8
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.CD134/CD137 双共刺激诱导的 IFN-γ 最大限度地提高效应 T 细胞功能,但限制 Treg 扩增。
Immunol Cell Biol. 2013 Feb;91(2):173-83. doi: 10.1038/icb.2012.74. Epub 2013 Jan 8.
9
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.用肿瘤或可溶性抗原启动后,CD8 T细胞效应功能获得方面的缺陷可通过添加OX40激动剂来克服。
J Immunol. 2007 Dec 1;179(11):7244-53. doi: 10.4049/jimmunol.179.11.7244.
10
Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.共刺激赋予免疫治疗性CD8 T细胞在有氧糖酵解过程中对白细胞介素-36的反应性。
J Immunol. 2016 Jan 1;196(1):124-34. doi: 10.4049/jimmunol.1501217. Epub 2015 Nov 16.

引用本文的文献

1
Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.调节性 T 细胞通过限制 IL-2 的作用来抑制表达 KLRK1 和 IL-7R 的效应性 CD8 T 细胞的形成。
Elife. 2023 Jan 27;12:e79342. doi: 10.7554/eLife.79342.
2
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.OX40(ivuxolimab)和 4-1BB(utomilumab)激动性抗体联合用于晚期实体瘤患者的首次人体研究。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005471.
3
Optimal CD8 T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape.
最佳的 CD8 T 细胞效应功能需要共刺激诱导的 RNA 结合蛋白,这些蛋白可重新编程转录本异构体景观。
Nat Commun. 2022 Jun 20;13(1):3540. doi: 10.1038/s41467-022-31228-0.
4
Evaluating the glycolytic potential of mouse costimulated effector CD8 T cells .评估小鼠共刺激效应性 CD8 T 细胞的糖酵解潜力。
STAR Protoc. 2022 Jun 3;3(2):101441. doi: 10.1016/j.xpro.2022.101441. eCollection 2022 Jun 17.
5
Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling.烟酰胺通过靶向mTOR信号传导破坏效应性CD8 T细胞反应。
iScience. 2022 Feb 15;25(3):103932. doi: 10.1016/j.isci.2022.103932. eCollection 2022 Mar 18.
6
Recombinant delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model.携带人巨噬细胞移动抑制因子(MIF)和白细胞介素-7(IL-7)融合蛋白的重组蛋白通过在荷瘤小鼠模型中诱导针对 MIF 的免疫应答发挥抗癌作用。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-003180.
7
CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma.基于CD137激动剂的联合免疫疗法可增强活化的效应记忆T细胞,并延长胰腺癌患者的生存期。
Cancer Lett. 2021 Feb 28;499:99-108. doi: 10.1016/j.canlet.2020.11.041. Epub 2020 Nov 30.
8
T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity.T 细胞共刺激与靶向 FAK 联合作用可增强抗肿瘤免疫。
Elife. 2020 Jan 21;9:e48092. doi: 10.7554/eLife.48092.
9
A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors.4-1BB(CD137)和 OX40(CD134)受体共刺激 CD8 T 细胞的数学模型。
Sci Rep. 2019 Jul 26;9(1):10862. doi: 10.1038/s41598-019-47333-y.
10
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.共刺激诱导 CD4+T 细胞抗肿瘤免疫是通过一种先天样机制。
Cell Rep. 2019 Apr 30;27(5):1434-1445.e3. doi: 10.1016/j.celrep.2019.04.016.